- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRNA
Recent news which mentions MRNA
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
November 24, 2023
Tickers
MRNA
From Benzinga
3 Biotech Stocks That Could Be Millionaire Makers
November 22, 2023
From Motley Fool
Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls
November 21, 2023
From Benzinga
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?
November 21, 2023
From Benzinga
Don’t Let the Q3 Earnings Miss Keep You From These 3 Stocks!
November 20, 2023
From InvestorPlace
3 Cathie Wood Bargain Buys That Should Be on Your List Too
November 13, 2023
From Motley Fool
Where Will Novavax Be in 3 Years?
November 11, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
From Benzinga
2 Top Biotech Stocks to Buy Right Now
November 10, 2023
From Motley Fool
Why Moderna Stock Was Cratering This Week
November 10, 2023
From Motley Fool
Novavax shares rise as third quarter results top expectations
November 09, 2023
From MarketWatch
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
November 09, 2023
Tickers
MRNA
From Motley Fool
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%
November 08, 2023
From InvestorPlace
High Risk Alert: 7 Vulnerable Stocks to Dump Now
November 07, 2023
From InvestorPlace
BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection Test
November 07, 2023
From Benzinga
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
November 07, 2023
From Motley Fool
Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You?
November 07, 2023
From Motley Fool
From Benzinga
Down 84% From Its Peak. Is It Finally Time to Buy Moderna?
November 05, 2023
From Motley Fool
Moderna May Be Facing Its Toughest Moment Ever. Time to Sell?
November 04, 2023
From Motley Fool
These Analysts Cut Their Forecasts On Moderna After Q3 Results
November 03, 2023
Tickers
MRNA
From Benzinga
Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
November 03, 2023
From Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
November 02, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.